BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23507607)

  • 1. [A case of locally advanced sigmoid colon cancer curatively resected after neoadjuvant chemotherapy with FOLFIRI plus panitumumab].
    Horioka K; Kaku K; Jimi S; Oohata Y; Kamei T
    Gan To Kagaku Ryoho; 2013 Mar; 40(3):397-9. PubMed ID: 23507607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of curatively resected sigmoid colon cancer after mFOLFOX6 plus panitumumab neoadjuvant chemotherapy].
    Yoshikawa K; Kuwata H; Nakahata Y
    Gan To Kagaku Ryoho; 2014 Mar; 41(3):399-401. PubMed ID: 24743293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Two cases of locally advanced colorectal cancer curatively resected after neoadjuvant chemotherapy with 5-fluorouracil, leucovorin, and oxaliplatin plus panitumumab].
    Nakayasu Y; Yoshimatsu K; Yokomizo H; Osawa G; Yano Y; Nakayama M; Sakuma A; Yamaguchi K; Shiozawa S; Shimakawa T; Katsube T; Naritaka Y
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2029-31. PubMed ID: 24394002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer.
    Peeters M; Price TJ; Cervantes A; Sobrero AF; Ducreux M; Hotko Y; André T; Chan E; Lordick F; Punt CJ; Strickland AH; Wilson G; Ciuleanu TE; Roman L; Van Cutsem E; Tzekova V; Collins S; Oliner KS; Rong A; Gansert J
    J Clin Oncol; 2010 Nov; 28(31):4706-13. PubMed ID: 20921462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open-label, single-arm, phase 2 trial of panitumumab plus FOLFIRI as second-line therapy in patients with metastatic colorectal cancer.
    Cohn AL; Shumaker GC; Khandelwal P; Smith DA; Neubauer MA; Mehta N; Richards D; Watkins DL; Zhang K; Yassine MR
    Clin Colorectal Cancer; 2011 Sep; 10(3):171-7. PubMed ID: 21855038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and safety of panitumumab administered concomitantly with FOLFIRI or Irinotecan in second-line therapy for metastatic colorectal cancer: the secondary analysis from STEPP (Skin Toxicity Evaluation Protocol With Panitumumab) by KRAS status.
    Mitchell EP; Piperdi B; Lacouture ME; Shearer H; Iannotti N; Pillai MV; Xu F; Yassine M
    Clin Colorectal Cancer; 2011 Dec; 10(4):333-9. PubMed ID: 22000810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of long-term survival following chemotherapy after laparoscopic resection of sigmoid colon cancer with multiple liver metastases].
    Ohashi I; Arai I; Tamura C; Hayashi N; Inoue S; Wakasa T
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1758-60. PubMed ID: 25731320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of sigmoid colon cancer with liver and ovarian metastases effectively treated by panitumumab after acquiring resistance to prior chemotherapy regimens].
    Honda K; Hata Y; Ihara E; Tomita Y; Miyata S; Sumida Y; Ihara Y; Misawa T
    Gan To Kagaku Ryoho; 2011 Sep; 38(9):1533-6. PubMed ID: 21918357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of liver metastasis from sigmoid colon cancer treated effectively by second-line chemotherapy].
    Gokita K; Ami K; Matsunaga Y; Fujiya K; Ohshima N; Amagasa H; Ganno H; Imai K; Fukuda A; Nagahama T; Ando M; Akita H; Tei S; Okada Y; Arai K
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1761-3. PubMed ID: 25731321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Two cases of metastatic colorectal cancer in wild-type K-RAS effectively treated by panitumumab].
    Ishiyama Y; Kotake M; Matsunaga M; Kitamura H; Yamamoto M; Inaki N; Kurokawa M; Bando H; Yamada T
    Gan To Kagaku Ryoho; 2012 Oct; 39(10):1567-70. PubMed ID: 23064074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutant KRAS codon 12 and 13 alleles in patients with metastatic colorectal cancer: assessment as prognostic and predictive biomarkers of response to panitumumab.
    Peeters M; Douillard JY; Van Cutsem E; Siena S; Zhang K; Williams R; Wiezorek J
    J Clin Oncol; 2013 Feb; 31(6):759-65. PubMed ID: 23182985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of locally advanced colorectal cancer with abscess responding to 5-fluorouracil, leucovorin, and oxaliplatin plus bevacizumab].
    Kuwabara H; Watanabe S; Liu B; Mitsuoka A; Sanada T; Nakajima K; Goseki N
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2032-4. PubMed ID: 24394003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of locally advanced rectal cancer successfully resected after preoperative chemotherapy].
    Hiraki S; Kuwahara T; Kaneko T; Harada T; Kawaoka T; Fukuda S
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1947-9. PubMed ID: 24393975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEAK: a randomized, multicenter phase II study of panitumumab plus modified fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) or bevacizumab plus mFOLFOX6 in patients with previously untreated, unresectable, wild-type KRAS exon 2 metastatic colorectal cancer.
    Schwartzberg LS; Rivera F; Karthaus M; Fasola G; Canon JL; Hecht JR; Yu H; Oliner KS; Go WY
    J Clin Oncol; 2014 Jul; 32(21):2240-7. PubMed ID: 24687833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experience of Ramucirumab plus FOLFIRI as Second-Line Treatment for Metastatic Colorectal Cancer in Our Hospital].
    Hagino S; Miyata T; Sakamoto K
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1559-1561. PubMed ID: 29394701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of pathologically complete response in a patient with locally advanced sigmoid colon cancer after chemotherapy including bevacizumab/FOLFOX4].
    Mikami Y; Tamura N; Akiyama M; Muraoka T; Sakurai U; Sawabe M
    Gan To Kagaku Ryoho; 2014 Jun; 41(6):777-9. PubMed ID: 25129094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life analysis in patients with KRAS wild-type metastatic colorectal cancer treated first-line with cetuximab plus irinotecan, fluorouracil and leucovorin.
    Láng I; Köhne CH; Folprecht G; Rougier P; Curran D; Hitre E; Sartorius U; Griebsch I; Van Cutsem E
    Eur J Cancer; 2013 Jan; 49(2):439-48. PubMed ID: 23116683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A Case of Simultaneous Laparoscopic Resection of Sigmoid Colon Cancer and Liver Metastases after Chemotherapy with Modified FOLFOX6 plus Panitumumab].
    Terada I; Amaya K; Watanabe T; Terai S; Kawahara Y; Yamamoto S; Kaji M; Maeda K; Shimizu K
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2166-8. PubMed ID: 26805299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of sigmoid colon cancer with abdominal wall abscess].
    Yamamoto Y; Shimizu S; Maruyama T; Tanaka H; Matsuzaki H; Natsume T; Miyazaki A; Satoh Y; Satsuka T; Yoshioka T; Kanada Y; Otsuka R; Yanagihara A; Yokoyama M; Kobayashi T
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1779-81. PubMed ID: 25731327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status.
    Van Cutsem E; Köhne CH; Láng I; Folprecht G; Nowacki MP; Cascinu S; Shchepotin I; Maurel J; Cunningham D; Tejpar S; Schlichting M; Zubel A; Celik I; Rougier P; Ciardiello F
    J Clin Oncol; 2011 May; 29(15):2011-9. PubMed ID: 21502544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.